Artificial Intelligence and Machine Learning – Webinars and Online Events

In this webinar, our expert speakers will explore how targeted integration techniques can significantly enhance the efficiency and reliability of engineering CHO cell models for drug discovery.

This event will explore the latest innovations, including automation, miniaturization and data analysis techniques.

In this live "Ask Me Anything" session, Dr. Lukas Lange, CEO and co-founder of Probably Genetic, will answer your questions about the transformative power of precision medicine in addressing rare genetic disorders.

This webinar will explore the latest advancements in quantitative metabolomics profiling, highlighting how standardized assays and AI-driven data analysis are enabling researchers to study over 1,200 metabolites across 49 biochemical classes.

Join us on March 12 for an exclusive Ask Me Anything session with Mike Ward, Head of Thought Leadership at Clarivate, as we explore the latest advancements in cell and gene therapy.

New for 2025, this event will cover the innovative technologies driving this field, including next-generation sequencing, liquid biopsy, AI-driven diagnostic tools and their integration into clinical practice to transform patient outcomes.

Focused on cutting-edge methods to reduce energy consumption in laboratories, enable green chemistry and AI/ML directed work flows.

New for 2025, this event will provide insights from both big pharma and emerging biotech firms. Attendees will gain a comprehensive understanding of how rapid technological advancements are reshaping therapeutic development and delivery.

This webinar explores the current state and potential of machine learning in drug discovery, providing clarity amidst the buzz surrounding AI integration.

In this webinar, Professor Jeffrey Skolnick will introduce POLYPHARM-AI, a suite of AI algorithms designed to identify common driver proteins shared across multiple comorbid diseases.